[1]
Miura, Y. et al. 2014. Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 31, 3 (Oct. 2014), 235–238.